OSL wins Cortex contract

Posted on Jan 04, 2012

Oncology Systems Limited has signed a five year distribution deal with US-based fiducial marker manufacturer Cortex, the people behind the original ACCULOC markers. The contract will see OSL sell the advanced implanted marker line in the UK and Ireland.

Stuart Baldwin, OSL’s sales director said: “This revolutionary new range of advanced markers complements our existing offerings and gives us the flexibility to offer a complete solution for all treatment sites and imaging modalities including new breast markers and markers that show up equally well in both CT and MR. The Cortex range offers some interesting new benefits for treatment delivery, which from previous conversations in many radiotherapy departments, will be of great interest to users.”


This page was printed from OSL Web site at http://www.osl.uk.com